• Home >
  • Publications >
  • In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 <sup>+</sup> T <sub>H</sub> 1 cell response

In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 <sup>+</sup> T <sub>H</sub> 1 cell response

24 Dec 2021Science Immunology

DOI : 10.1126/sciimmunol.abe8219

Authors

Aurélien Sutra Del Galy, Silvia Menegatti, Jaime Fuentealba, Francesca Lucibello, Laetitia Perrin, Julie Helft, Aurélie Darbois, Michael Saitakis, Jimena Tosello, Derek Rookhuizen, Marc Deloger, Pierre Gestraud, Gérard Socié, Sebastian Amigorena, Olivier Lantz, Laurie Menger

Abstract

Inactivation of SOCS1 optimizes adoptive T cell therapy including human CAR-T cell composition and efficacy.

Teams

Team

Immune responses to cancer

SEBASTIAN AMIGORENA

Members

SEBASTIAN AMIGORENA

Directeur de recherche CNRS

PIERRE GESTRAUD

Ingénieur de recherche

OLIVIER LANTZ

Médecin